Skip to main content
International Journal of Clinical and Experimental Medicine logoLink to International Journal of Clinical and Experimental Medicine
. 2015 Oct 15;8(10):18533–18537.

Yiqi Huayu recipe relieves nerve root constriction induced radicular neuralgia by down-regulating TRPV4 expression in dorsal root ganglion

Zhanying Tang 1,*, Xuejun Cui 1,*, Zhijun Hu 1, Jing Xiao 1, Weiwei Li 1, Qiangling Yang 1, Dan Liu 1, Jie Lin 1, Yongjun Wang 1, Qi Shi 1
PMCID: PMC4694365  PMID: 26770465

Abstract

The aim of this study was to observe the effects of Yiqi Huayu recipe on TRPV4 expression in radicular neuralgia model induced by chronic constriction to the rat lumber nerve root. Healthy male SD rats were divided into 3 groups for radicular neuralgia (RN) model construction: the sham operation group, model groups (day 3, 7, 14 and 28), and medication groups (day 3, 7, 14 and 28). Von-Frey hairs test was performed to detect the 50% with drawal threshold (50% TPW) for rats of each group. The expression of TRPV4 in dorsal root ganglion was detected at both mRNA and protein level. Rats from all model groups displayed hyperalgesia with significantly reduced 50% TPW values compared with sham-operation group (P<0.01); Yiqi Huayu recipe medication groups showed higher 50% TPW than model group since 7 days post medication (P<0.01); the medication groups showed decreased TRPV4 expression than that of model groups (P<0.01). In conclusion, Yiqi Huayu recipe alleviates nerve root constriction induced radicular neuralgia by repressing TRPV4 expression in dorsal root ganglion.

Keywords: Dorsal root ganglion, hyperalgesia, TRPV4

Introduction

Frequently caused by noxious stimuli including mechanical pressure and inflammatory stimulus on dorsal root ganglion (DRG), radicular neuralgia (RN) is the common symptom of spinal diseases [1]. Clinically speaking, RN could be originated from DRG lesions caused by lumbar disc protrusion, spinal canal stenosis, lumbar spinal instability, hypertrophy of ligamentum flavum, zygapophyseal joints hyperplasia, tumors in vertebral canal, or other spinal space occupying diseases [2-4].

Among numerous ion channels in DRG neuron membrane, transient receptor potential vanilloid channel 4 (TRPV4) plays important roles in RN caused by DRG lesions [5,6]. TRPV4 is a non-selective cation channel with medium permeability to Ca2+ and the sensory transducer of harmful stimulus caused by hypotonic stimulation [7]. The happening of Ca2+ influx through TRPV4 occurs upon the perception of ambient pressure. The elevated cellular Ca2+ level not only elites series of physiological responses, including releasing of pain transmitters and activation of PKA/PKC signaling pathway [8], but also activates Ca2+/calmodulin dependent protein kinases that produce chains of pathological reactions [9]. TRPV4 is widely expressed in various tissues. Immunohistochemistry evidence showed that TRPV4 is localized in membrane, cytoplasmic vesicles, and nucleus of DRG neurons in rat [5,10].

Following the dialectical theory of Shi’s traumatology (yi qi wei zhu, yi xue wei xian) in spinal degenerative diseases, professor Qi She, from Shanghai University of Traditional Chinese Medicine, proposed the basic rule of Yiqi Huayu for the treatment of secondary RN caused by spinal degenerative diseases, and originally created the Yiqi Huayu recipe [11]. The preliminary study showed that Yiqi Huayu recipe composing Astragalus mongholicus and Ligusticum wallichii could effectively reduce inflammatory responses of RN, inhibit hypernomic permeability of capillary hyperplasia, abate content of inflammatory mediators (PGE2 and PLA2), and improve microcirculation [11], while the underlying molecular mechanism is largely unknown. In this study, we generated the rat RN model via DRG constriction. Based on the model, we observed the TRPV4 expression changes and therapeutic effects of Yiqi Huayu recipe at different time points of constriction on DRG.

Materials and methods

Animals

Ninety male rats (SPF, 3 months, weight 250-300 g, certificate number: 2007000542991) were purchased from Shanghai SLAC experimental animal, LLC. These rats were randomly divided into 3 groups: 10 for sham-operated group, 40 for model group, and 40 for medication group. The model and medication groups were further evenly divided into day 3, 7, 14 and 28 groups.

Waist DRG constriction model and medication

This model was constructed based on the previously described constriction model with silica gel sheet. Silica gel sheets (2×2×1 mm, 10±1.5 mg) were disinfected in 75% ethanol for 2 hours and stored in bromo-geramine. The rats were anaesthetized by intraperitoneal injection of etamine (0.1 ml/100 g). After fur shaving around waist and hip, rats were regularly disinfected and covered with aseptic towel. Incision was made to the middle right of L4-L5 spinous process. After consecutive exposure of skin, lumbodorsal fascia, lumbar longissimus muscle, multifidus, and musculi semispinalis dorsi, blunt dissection was made to expose processus transversus. The premade silica gel sheet was horizontally inserted into the foramen of L4-L5 to exert pressure on DRG. After sutures and analepsia, the rats were raised in cage for observation. The sham group underwent the same operation procedures except for the insertion of silica gel sheet. The Yiqi Huayu recipe was composed of 15 g Astragalus mongholicus, 12 g Codonopsis pilosula, 9 g Ligusticum wallichii, 9 g Salvia miltiorrhiza, and 0.03 g muscone. Rats from day 3, 7, 14 or 28 medication groups were subjected to 28 days’ intragastric administration of water decoction of the recipe 3, 7, 14 or 28 post-surgery days, respectively. Medication was performed twice a day.

Daily dose (per rat) = Daily dose (per human adult) × Body surface of rat/Body surface of human

DRG sampling

The rapid DRG isolation was performed according to the previous method [12]. The rats were deeply anaesthetized by injection of 2% pentobarbital sodium (50 mg/kg). After decapitation, the lumbar spine was peeled and DRG was isolated and stored in liquid nitrogen.

Threshold testing of 50% paw withdraw (50% TPW)

The sham and experimental groups were subjected to 50% TPW testing 3, 7, 14, and 28 post-surgery days. The up-down method developed by Dixon was used for 50% TPW measurement [13]. Testing was started at 2.0 g stimulus with Von Fry fiber pen to the middle of rear paws for 6-8 s. In the absence of a paw withdrawal response (negative, labeled as ‘○’), a stronger stimulus was exerted, while in the event of paw withdrawal (positive, labeled as ‘×’), a weaker stimulus was chosen. The paw withdrawal during or right after a stimulus was defined as positive response. The testing should be done while the rat was still. After the first positive response, 5 more tests were carried out with 5 s interval between two consecutive tests.

5% TPW = 10[Xf + κδ]/1000

Where Xf = value (in log units) of final von Frey hair used, κ = tabular value for the pattern of positive/negative responses, and δ = mean difference (in log units) between stimuli.

Quantitative reverse transcription polymerase chain reaction (qRT-PCR)

Total RNA for each group was extracted with DRN from each group. For each sample, 2 μg total RNA was used for cDNA synthesis (Promega, U.S.A.). SYBR master mix (Shanghai Jingmei Biological Engineering, Co., Ltd.) was used for qRT-PCR (Lightcycler 2.0, Roche, Switzerland). Primers for each gene were purchased from Life technologies, U.S.A. TRPV4 forward: 5’-AAGTGGCGTAAGTTCGGG-3’; TRPV4 reverse: 5’-TAAGGGTAGGGTGGCGTG-3’; β-actin forward: 5’-AGACCTTCAACACCCCAG-3’; β-actin reverse: 5’-CACGTTTCCCTCTCAGC-3’.

Western blotting

Total protein was extracted with DRN samples from each group. The protein samples were quantified with Bradford method, separated by sodium dodecylsulfate-polyacrylamide gel electrophoresis (SDS-PAGE), and electro-transferred onto polyvinylidenedifluoride (PVDF) membrane. After blocking, the membrane was incubated with respective primary antibody (TRPV4 antibody: Alomone, Israel; β-actin antibody: Abcam, U.K.) and horseradish peroxidase conjugated secondary antibody consecutively. The protein bands were visualized with Flurochem 9900-50 gel imaging system (Alpha Innotech, U.S.A.).

Statistical analysis

SPSS10.0 was used for all the statistical analysis. Comparison between groups was performed with pairwise T-test, whereas comparisons among several groups were carried out with analysis of variance.

Results

Yiqi Huayu recipe relieves RN caused by constant mechanical constriction

After surgery, rats from all the model groups displayed significantly reduced 50% TPW values than sham-operation group (P<0.01) (Table 1). The 50% TPW value of model group declined to trough at 7 days post surgery. Below the basal line of sham group, the 50% TPW of model group raised up slowly since 7 days post-surgery. Three days post recipe intervention, both model and medication groups showed lower 50% TPW values than sham group (P<0.01), while no 50% TPW difference between model and medication group was observed (P>0.05) (Table 1). After medication, rats from day 7, 14 and 28 groups had higher 50% TPW values when compared with responsive model groups (P<0.01). And after more than 14 days’ medication, the pain sensitivity recovered to the level of sham-operation group (P>0.05).

Table 1.

50% TPW values post mechanistic stimuli for each group ( ± s)

Groups Basal Day 3 Day 7 Day 14 Day 28
Sham 17.7±0.82 17.2±1.22 18.0±1.31 16.5±0.98 17.1±0.82
Model 17.5±0.79 8.7±1.16ΔΔ 4.7±0.67ΔΔ 8.0±0.94ΔΔ 11.2±0.79ΔΔ
Medication 17.1±0.97 8.1±0.88ΔΔ 13.4±0.70ΔΔ,** 15.7±0.82** 16.8±0.63**

Note: For comparisons with sham group, Δrepresent P<0.05;

ΔΔ

represent P<0.01.

For comparisons between corresponding model and medication group, *represent P<0.05;

**

represent P<0.01.

Yiqi Huayu recipe down-regulates RN induced TRPV4 expression

Constant mechanistic constriction up-regulated TRPV4 expression at both mRNA (Figure 1) and protein levels (Figures 2 and 3). Compared with sham group, enhanced TRPV4 expression was observed in all the model groups at both mRNA and protein level (P<0.01). Day 3, 7 and 14 medication groups still had higher level of TRPV4 mRNA compared with sham group (P<0.01), while no significant difference of TRPV4 mRNA level was observed between day 28 medication group and sham group (P>0.05). Three days post medication, no expressional difference of TRPV4 mRNA was developed between model and medication group (P>0.05), whereas day 7, 14 and 28 medication group had lower TRPV4 mRNA expression than day 7, 14 and 28 model group, respectively (P<0.01).

Figure 1.

Figure 1

TRPV4 mRNA expression for each group. Basal line indicates the TRPV4 mRNA expression level of sham group. For comparisons with sham group, Δ and ΔΔ represent P<0.05 and P<0.01, respectively; for comparisons between corresponding model and medication group, * and ** represent P<0.05 and P<0.01, respectively.

Figure 2.

Figure 2

Expression changes of TRPV4 protein in each group’s DRG neuron. Basal line indicates the TRPV4 protein level of sham group. For comparisons with sham group, Δ and ΔΔ represent P<0.05 and P<0.01, respectively.

Figure 3.

Figure 3

Expression of TRPV4 protein for all groups. GAPDH was served as internal reference.

Discussion

Previous reports showed that constant constriction on rat’s DRG significantly induced the expression of TRPV4, abated both mechanical and hyperthermal pain threshold values, increased the ratio of neurons responsive to hypotonic solution and 4α-PDD in DRG, and elevated cytoplasmic Ca2+ concentration, while TRPV4 knockdown partially rescued the abnormal algesia [14,15]. Our results showed that 50% TPW value and TRPV4 expression were positively correlated with the constriction time length, further confirming the importance of TRPV4 in RN by DRG constriction. Following Yiqi Huayu recipe intervention, the down-regulated expression of TRPV4 and relief of RG indicate that Yiqi Huayu could alleviate RN by down-regulating TRPV4 expression.

The classical route of drug development is to develop selective ligand that acts on single disease target to obtain highly effective and safe drug with low side effects, while there is a decline in the number of new drugs launched into the clinical field in the past decades [16]. The main explanation to this phenomenon is the fact that the pathogenesis of most diseases is multi-factorial rather than single target involved. The complexity of Chinese traditional medicine makes it possible to act on multiple targets of a certain disease simultaneously [17]. The inhibitory effect of Yiqi Huayu recipe on the transcription of TRPV4 is the functional output of many active ingredients within the recipe. The transcription factors (TFs) binding to TRPV4 promoter are the potential targets of Yiqi Hueyu recipe. By analyzing consensus motifs within TRPV4 promoter and utilizing chromatin immuno-precipitation technologies, TFs directly regulating TRPV4 transcription could be identified and studied. Further investigations could be made to check the responses of the above TFs upon the treatment of Yiqi Huayu recipe.

In conclusion, our results indicate that Yiqi Huayu recipe could alleviate RN caused by constant constriction on DRG through repressing TRPV4 expression in rat model. Our findings are helpful for better understanding to molecular mechanism of RN, and informative for the development of effective therapeutic methods against RN.

Acknowledgements

The research was supported by the National Natural Science Foundation of China (No. 81102605); Shanghai Science and Technology Basic Research Program (No. 12ZR1431900); Shanghai Kyorin Nova plan (No. ZYSNXD011-RC-XLXX-20130052) Advanced and Appropriate Technology Promotion Projects of Shanghai Municipal Health Bureau (No. 2013SY014).

Disclosure of conflict of interest

None.

References

  • 1.Gilron I, Watson CP, Cahill CM, Moulin DE. Neuropathic pain: a practical guide for the clinician. CMAJ. 2006;175:265–275. doi: 10.1503/cmaj.060146. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 2.Moulin DE, Clark AJ, Gilron I, Ware MA, Watson CP, Sessle BJ, Coderre T, Morley-Forster PK, Stinson J, Boulanger A, Peng P, Finley GA, Taenzer P, Squire P, Dion D, Cholkan A, Gilani A, Gordon A, Henry J, Jovey R, Lynch M, Mailis-Gagnon A, Panju A, Rollman GB, Velly A. Pharmacological management of chronic neuropathic pain-consensus statement and guidelines from the Canadian Pain Society. Pain Res Manag. 2007;12:13–21. doi: 10.1155/2007/730785. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 3.Schmader KE. Epidemiology and impact on quality of life of postherpetic neuralgia and painful diabetic neuropathy. Clin J Pain. 2002;18:350–354. doi: 10.1097/00002508-200211000-00002. [DOI] [PubMed] [Google Scholar]
  • 4.Chaparro LE, Wiffen PJ, Moore RA, Gilron I. Combination pharmacotherapy for the treatment of neuropathic pain in adults. Cochrane Database Syst Rev. 2012;7:CD008943. doi: 10.1002/14651858.CD008943.pub2. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 5.Suzuki M, Mizuno A, Kodaira K, Imai M. Impaired pressure sensation in mice lacking TRPV4. J Biol Chem. 2003;278:22664–22668. doi: 10.1074/jbc.M302561200. [DOI] [PubMed] [Google Scholar]
  • 6.Liedtke W, Tobin DM, Bargmann CI, Friedman JM. Mammalian TRPV4 (VR-OAC) directs behavioral responses to osmotic and mechanical stimuli in Caenorhabditis elegans. Proc Natl Acad Sci U S A. 2003;100(Suppl 2):14531–14536. doi: 10.1073/pnas.2235619100. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 7.Alessandri-Haber N, Yeh JJ, Boyd AE, Parada CA, Chen X, Reichling DB, Levine JD. Hypotonicity induces TRPV4-mediated nociception in rat. Neuron. 2003;39:497–511. doi: 10.1016/s0896-6273(03)00462-8. [DOI] [PubMed] [Google Scholar]
  • 8.Poole DP, Amadesi S, Veldhuis NA, Abogadie FC, Lieu T, Darby W, Liedtke W, Lew MJ, McIntyre P, Bunnett NW. Protease-activated receptor 2 (PAR2) protein and transient receptor potential vanilloid 4 (TRPV4) protein coupling is required for sustained inflammatory signaling. J Biol Chem. 2013;288:5790–5802. doi: 10.1074/jbc.M112.438184. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 9.Alessandri-Haber N, Dina OA, Joseph EK, Reichling D, Levine JD. A transient receptor potential vanilloid 4-dependent mechanism of hyperalgesia is engaged by concerted action of inflammatory mediators. J Neurosci. 2006;26:3864–3874. doi: 10.1523/JNEUROSCI.5385-05.2006. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 10.Grant AD, Cottrell GS, Amadesi S, Trevisani M, Nicoletti P, Materazzi S, Altier C, Cenac N, Zamponi GW, Bautista-Cruz F, Lopez CB, Joseph EK, Levine JD, Liedtke W, Vanner S, Vergnolle N, Geppetti P, Bunnett NW. Protease-activated receptor 2 sensitizes the transient receptor potential vanilloid 4 ion channel to cause mechanical hyperalgesia in mice. J Physiol. 2007;578:715–733. doi: 10.1113/jphysiol.2006.121111. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 11.Zhou CJ, Wang YJ, Shi Q, Hou BX, Liu M. [Effect of Yiqi Huayu Recipe on regeneration process after L5 nerve root compression in rats] . Zhong Xi Yi Jie He Xue Bao. 2003;1:277–280. doi: 10.3736/jcim20030414. [DOI] [PubMed] [Google Scholar]
  • 12.Gold MS, Dastmalchi S, Levine JD. Co-expression of nociceptor properties in dorsal root ganglion neurons from the adult rat in vitro. Neuroscience. 1996;71:265–275. doi: 10.1016/0306-4522(95)00433-5. [DOI] [PubMed] [Google Scholar]
  • 13.Chaplan SR, Bach FW, Pogrel JW, Chung JM, Yaksh TL. Quantitative assessment of tactile allodynia in the rat paw. J Neurosci Methods. 1994;53:55–63. doi: 10.1016/0165-0270(94)90144-9. [DOI] [PubMed] [Google Scholar]
  • 14.Zhang Y, Wang Y, Ding X, Wang Y, Wang R, Yue S. The role of transient receptor potential vanilloid 4 in mediating mechanical and thermal allodynia following chronic compression of dorsa root ganglion in rats. Chinese Journal of Rehabilitation Medicine. 2010;25:1123–1130. [Google Scholar]
  • 15.Meng X, Yue T, Chen R, Wang Y, Zhang Y. The Effect of TRPV4 Channel Protein Expression on Pain Threshold after Dorsal Root Ganglia Oppressed. Clinical Medical Engineering. 2011;18:495–496. [Google Scholar]
  • 16.Xu Y, Li XJ. [Multi-target therapeutics and new drug discovery] . Yao Xue Xue Bao. 2009;44:226–230. [PubMed] [Google Scholar]
  • 17.Efferth T, Koch E. Complex interactions between phytochemicals. The multi-target therapeutic concept of phytotherapy. Curr Drug Targets. 2011;12:122–132. doi: 10.2174/138945011793591626. [DOI] [PubMed] [Google Scholar]

Articles from International Journal of Clinical and Experimental Medicine are provided here courtesy of e-Century Publishing Corporation

RESOURCES